These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10341878)

  • 1. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
    Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
    Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
    Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
    Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
    Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
    Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity.
    Dressman D; Araishi K; Imamura M; Sasaoka T; Liu LA; Engvall E; Hoffman EP
    Hum Gene Ther; 2002 Sep; 13(13):1631-46. PubMed ID: 12228018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice.
    Allamand V; Donahue KM; Straub V; Davisson RL; Davidson BL; Campbell KP
    Gene Ther; 2000 Aug; 7(16):1385-91. PubMed ID: 10981665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.
    Cordier L; Hack AA; Scott MO; Barton-Davis ER; Gao G; Wilson JM; McNally EM; Sweeney HL
    Mol Ther; 2000 Feb; 1(2):119-29. PubMed ID: 10933922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle.
    Abadie J; Blouin V; Guigand L; Wyers M; Cherel Y
    Gene Ther; 2002 Aug; 9(15):1037-43. PubMed ID: 12101435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
    Herson S; Hentati F; Rigolet A; Behin A; Romero NB; Leturcq F; Laforêt P; Maisonobe T; Amouri R; Haddad H; Audit M; Montus M; Masurier C; Gjata B; Georger C; Cheraï M; Carlier P; Hogrel JY; Herson A; Allenbach Y; Lemoine FM; Klatzmann D; Sweeney HL; Mulligan RC; Eymard B; Caizergues D; Voït T; Benveniste O
    Brain; 2012 Feb; 135(Pt 2):483-92. PubMed ID: 22240777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
    Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
    Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer.
    Holt KH; Lim LE; Straub V; Venzke DP; Duclos F; Anderson RD; Davidson BL; Campbell KP
    Mol Cell; 1998 May; 1(6):841-8. PubMed ID: 9660967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene analysis in patients with muscular dystrophy: alpha-sarcoglycan (adhalin) gene mutations in patients with malignant limb-girdle muscular dystrophy].
    Akaike M; Kawai H
    Rinsho Byori; 1997 Feb; 45(2):136-40. PubMed ID: 9120997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.
    Stedman H; Wilson JM; Finke R; Kleckner AL; Mendell J
    Hum Gene Ther; 2000 Mar; 11(5):777-90. PubMed ID: 10757357
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
    Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
    Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population].
    Hayashi YK; Arahata K
    Nihon Rinsho; 1997 Dec; 55(12):3165-8. PubMed ID: 9436429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy.
    Kawada T; Sakamoto A; Nakazawa M; Urabe M; Masuda F; Hemmi C; Wang Y; Shin WS; Nakatsuru Y; Sato H; Ozawa K; Toyo-oka T
    Biochem Biophys Res Commun; 2001 Jun; 284(2):431-5. PubMed ID: 11394897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
    Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
    Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.